Literature DB >> 14697762

Multiple TPR motifs characterize the Fanconi anemia FANCG protein.

Eric Blom1, Henri J van de Vrugt, Yne de Vries, Johan P de Winter, Fré Arwert, Hans Joenje.   

Abstract

The genome protection pathway that is defective in patients with Fanconi anemia (FA) is controlled by at least eight genes, including BRCA2. A key step in the pathway involves the monoubiquitylation of FANCD2, which critically depends on a multi-subunit nuclear 'core complex' of at least six FANC proteins (FANCA, -C, -E, -F, -G, and -L). Except for FANCL, which has WD40 repeats and a RING finger domain, no significant domain structure has so far been recognized in any of the core complex proteins. By using a homology search strategy comparing the human FANCG protein sequence with its ortholog sequences in Oryzias latipes (Japanese rice fish) and Danio rerio (zebrafish) we identified at least seven tetratricopeptide repeat motifs (TPRs) covering a major part of this protein. TPRs are degenerate 34-amino acid repeat motifs which function as scaffolds mediating protein-protein interactions, often found in multiprotein complexes. In four out of five TPR motifs tested (TPR1, -2, -5, and -6), targeted missense mutagenesis disrupting the motifs at the critical position 8 of each TPR caused complete or partial loss of FANCG function. Loss of function was evident from failure of the mutant proteins to complement the cellular FA phenotype in FA-G lymphoblasts, which was correlated with loss of binding to FANCA. Although the TPR4 mutant fully complemented the cells, it showed a reduced interaction with FANCA, suggesting that this TPR may also be of functional importance. The recognition of FANCG as a typical TPR protein predicts this protein to play a key role in the assembly and/or stabilization of the nuclear FA protein core complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697762     DOI: 10.1016/j.dnarep.2003.09.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  26 in total

1.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

2.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 3.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

4.  RAD51D- and FANCG-dependent base substitution mutagenesis at the ATP1A1 locus in mammalian cells.

Authors:  John M Hinz; Salustra S Urbin; Larry H Thompson
Journal:  Mutat Res       Date:  2009-03-18       Impact factor: 2.433

5.  Selection and the cell cycle: positive Darwinian selection in a well-known DNA damage response pathway.

Authors:  Mary J O'Connell
Journal:  J Mol Evol       Date:  2010-11-04       Impact factor: 2.395

Review 6.  Nuclear alpha spectrin: Critical roles in DNA interstrand cross-link repair and genomic stability.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-01

7.  The functional importance of lamins, actin, myosin, spectrin and the LINC complex in DNA repair.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-04

Review 8.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

Review 9.  The Fanconi anemia/BRCA gene network in zebrafish: embryonic expression and comparative genomics.

Authors:  Tom A Titus; Yi-Lin Yan; Catherine Wilson; Amber M Starks; Jonathan D Frohnmayer; Ruth A Bremiller; Cristian Cañestro; Adriana Rodriguez-Mari; Xinjun He; John H Postlethwait
Journal:  Mutat Res       Date:  2008-12-03       Impact factor: 2.433

Review 10.  Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.

Authors:  Paul R Andreassen; Keqin Ren
Journal:  Curr Cancer Drug Targets       Date:  2009-02       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.